×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Cell: CNS Border-Associated Macrophages (BAMs)
cell
648 words
KG: CNS
2026-03-24
kind:cell-type
section:cell-types
state:published
Contents
CNS Border-Associated Macrophages (BAMs)
🧫
Cell Type Info
Cell Type
CNS Border-Associated Macrophages (BAMs)
Related Genes
BI-hTFR1
,
BDNF
Linked Hypotheses
3 hypotheses
Knowledge Graph
Related Hypotheses (14)
Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95
Score: 0.69
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68
Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57
Blood-Brain Barrier SPM Shuttle System
Score: 0.55
Senescent Cell Mitochondrial DNA Release
Score: 0.54
Glymphatic System-Enhanced Antibody Clearance Reversal
Score: 0.54
Multiplexed Base Editing for Simultaneous Neuroprotective Ge
Score: 0.53
Senescence-Associated Myelin Lipid Remodeling
Score: 0.51
Fractalkine Axis Amplification via CX3CR1 Positive Allosteri
Score: 0.50
Ocular Immune Privilege Extension
Score: 0.47
Enteric Nervous System Prion-Like Propagation Blockade
Score: 0.44
Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener
Score: 0.41
Optogenetic Microglial Deactivation via Engineered Inhibitor
Score: 0.38
Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem
Score: 0.38
Show 9 more
Related Analyses (21)
Systemic immune profiling and peripheral immune contribution
neurodegeneration · completed
Senescent cell clearance as neurodegeneration therapy
neurodegeneration · completed
Can IGFBPL1 therapeutics effectively cross the blood-brain b
drug delivery · failed
How can AQP4 be effectively targeted therapeutically to impr
neurodegeneration · failed
What are the specific molecular mechanisms by which AQP4 dys
neurodegeneration · failed
How can CNS-selective HDAC/DNMT inhibitors be developed to a
pharmacology · failed
Does CXCL10 inhibition compromise CNS immune surveillance du
neuroimmunology · failed
How can CRISPR systems achieve persistent therapeutic effect
gene therapy · failed
What determines blood-brain barrier penetration kinetics for
neuropharmacology · failed
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · failed
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · archived
Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · archived
Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · failed
Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
Show 16 more
Related Experiments (20)
IDH1 and IDH2 mutation sequencing in CNS and non-CNS tumors
exploratory · proposed · Score: 0.95
s:** - Biochemical binding assays measuring PROTAC selectivi
falsification · proposed · Score: 0.40
Proposed experiment from debate on Synaptic pruning by micro
falsification · proposed · Score: 0.40
s:** - Single-cell RNA-seq to measure editing efficiency acr
falsification · proposed · Score: 0.40
s:** - Dose-response studies showing therapeutic window with
falsification · proposed · Score: 0.40
4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.40
AAV-LRRK2 IND-Enabling Study Design
clinical · proposed · Score: 0.40
Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.40
CRISPR Gene Correction Approaches for CBS/PSP
clinical · proposed · Score: 0.40
Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
Macroautophagy Dysfunction in PD - Experiment Design
clinical · proposed · Score: 0.40
Progranulin Replacement Therapy for FTD — Vector Development
clinical · proposed · Score: 0.40
SCFA-Mediated Neuroinflammation in Alzheimer's Disease
clinical · proposed · Score: 0.40
Biomechanical Impact Profiles and Chronic Traumatic Encephal
clinical · proposed · Score: 0.40
QTJD effects on macrophage polarization and inflammatory res
exploratory · proposed · Score: 0.95
Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio
clinical · proposed · Score: 0.40
tACS Connectivity Trial in Early Alzheimer's
clinical · proposed · Score: 0.40
Microbiome-Gut Barrier Signatures in ALS — Experiment Design
clinical · proposed · Score: 0.40
Show 15 more
See Also (3)
BDNF Gene
gene · KG edge: expressed_in
Microglia in Neurodegeneration
entity · KG edge: expressed_in
Disease-Associated Microglia (DAM)
cell · KG edge: expressed_in
Knowledge Graph (7 edges)
BDNF
expressed_in
CNS
therapeutic agents
associated_with
CNS
BI-hTFR1
mediates
CNS
JEV
infects
CNS
MS
regulates
CNS
MICROGLIA
expressed_in
CNS
DAM
expressed_in
CNS